Financials DOD Biotech

Equities

DOD

TH8569010003

Food Processing

End-of-day quote Thailand S.E. 06:00:00 2024-05-02 pm EDT 5-day change 1st Jan Change
2.7 THB +1.50% Intraday chart for DOD Biotech +5.47% -27.03%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 5,576 2,993 3,608 4,592 1,788 1,667
Enterprise Value (EV) 1 5,151 3,087 3,670 4,614 1,986 1,767
P/E ratio 16.1 x 34.8 x 25.9 x 92.2 x -4.47 x 224 x
Yield - 4.79% - - - -
Capitalization / Revenue 8.28 x 3.76 x 2.23 x 4.51 x 3.26 x 2.35 x
EV / Revenue 7.65 x 3.88 x 2.26 x 4.53 x 3.62 x 2.49 x
EV / EBITDA 15.5 x 22.1 x 9.46 x 12.4 x -5.6 x 15.3 x
EV / FCF 20 x -6.09 x 32.1 x -3,181 x 107 x -76.2 x
FCF Yield 5.01% -16.4% 3.12% -0.03% 0.93% -1.31%
Price to Book 4.71 x 2.45 x 2.97 x 3.59 x 2.01 x 1.58 x
Nbr of stocks (in thousands) 410,000 410,000 410,000 410,000 410,000 450,414
Reference price 2 13.60 7.300 8.800 11.20 4.360 3.700
Announcement Date 2/21/19 2/27/20 3/1/21 2/24/22 2/22/23 2/23/24
1THB in Million2THB
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 673.1 795.9 1,621 1,018 548.3 710.1
EBITDA 1 332.6 139.6 387.9 373 -354.9 115.4
EBIT 1 311.4 86.22 319.2 310.8 -416.4 46.85
Operating Margin 46.26% 10.83% 19.7% 30.52% -75.94% 6.6%
Earnings before Tax (EBT) 1 307.6 78.24 166.7 265.1 -424.2 48.88
Net income 1 305.3 86.71 141.2 49.79 -398.3 7.187
Net margin 45.35% 10.89% 8.72% 4.89% -72.64% 1.01%
EPS 2 0.8473 0.2100 0.3400 0.1214 -0.9750 0.0165
Free Cash Flow 1 258.1 -507.2 114.5 -1.45 18.5 -23.18
FCF margin 38.34% -63.72% 7.06% -0.14% 3.37% -3.26%
FCF Conversion (EBITDA) 77.59% - 29.51% - - -
FCF Conversion (Net income) 84.55% - 81.04% - - -
Dividend per Share - 0.3500 - - - -
Announcement Date 2/21/19 2/27/20 3/1/21 2/24/22 2/22/23 2/23/24
1THB in Million2THB
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - 94.5 62.1 21.6 199 101
Net Cash position 1 425 - - - - -
Leverage (Debt/EBITDA) - 0.677 x 0.1602 x 0.058 x -0.5603 x 0.873 x
Free Cash Flow 1 258 -507 114 -1.45 18.5 -23.2
ROE (net income / shareholders' equity) 41.4% 6.07% 10.8% 18.7% -32% 2.11%
ROA (Net income/ Total Assets) 20.9% 3.62% 12.1% 11.5% -17.8% 2.13%
Assets 1 1,460 2,398 1,171 433.8 2,233 337.3
Book Value Per Share 2 2.890 2.970 2.960 3.120 2.160 2.350
Cash Flow per Share 2 0.3300 0.2000 0.3500 0.3900 0.0700 0.1500
Capex 1 38.1 289 128 183 63.3 18.1
Capex / Sales 5.67% 36.36% 7.87% 17.96% 11.54% 2.55%
Announcement Date 2/21/19 2/27/20 3/1/21 2/24/22 2/22/23 2/23/24
1THB in Million2THB
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Chiffre d''affaires - Rate of surprise

  1. Stock Market
  2. Equities
  3. DOD Stock
  4. Financials DOD Biotech